MedApp Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
David Odrakiewicz
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
CEO
David Odrakiewicz
1.2yrs
Tenure
Mr. David Odrakiewicz has been Chairman of Management Board at MedApp S.A. since October 4, 2023. Heserved as a Member of Supervisory Board at MedApp S.A. until November 11, 2016.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of the Supervisory Board | 6.2yrs | zł2.35k | no data | |
| Chairman of Supervisory Board | 6.4yrs | zł4.92k | no data | |
| Member of Scientific Council | 6.5yrs | no data | no data | |
| Member of Scientific Council | 6.5yrs | no data | no data | |
| Member of Scientific Council | 6.5yrs | no data | no data | |
| Member of Supervisory Board | 4.9yrs | zł4.92k | no data | |
| Member of Scientific Council | no data | no data | no data | |
| Member of the Supervisory Board | 1.7yrs | no data | no data | |
| Member of Supervisory Board | less than a year | no data | no data |
6.3yrs
Average Tenure
Experienced Board: MDA's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 03:56 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |